XML 41 R29.htm IDEA: XBRL DOCUMENT v3.8.0.1
Collaborative Arrangements - Janssen Biotech Agreement (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended
Feb. 28, 2018
Jan. 31, 2015
Mar. 31, 2018
Mar. 31, 2017
Collaborative Arrangements        
Percentage of profit share 33.00% 35.00%    
Revenue from collaborative arrangements     $ 4,640 $ 37
Revenue from the recognition of previously deferred revenue     16  
Janssen        
Collaborative Arrangements        
Upfront payment receivable $ 100,000      
Percentage of profit share 67.00%      
Maximum potential payments receivable $ 900,000      
Revenue from collaborative arrangements 4,600   $ 4,613  
Revenue from the recognition of previously deferred revenue 95,400      
Janssen | Collaborative Arrangement        
Collaborative Arrangements        
Milestone payment 700,000      
Janssen | Collaborative Arrangement | TD-1473        
Collaborative Arrangements        
Milestone payment $ 200,000